U.S. markets closed

Johnson & Johnson (JNJ)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
159.20-1.04 (-0.65%)
At close: 1:00PM EST
158.80 -0.40 (-0.25%)
After hours: 04:59PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Inside Bar (Bullish)

Inside Bar (Bullish)

Previous Close160.24
Bid158.66 x 800
Ask159.06 x 800
Day's Range158.66 - 161.16
52 Week Range143.06 - 179.92
Avg. Volume6,617,117
Market Cap419.11B
Beta (5Y Monthly)0.70
PE Ratio (TTM)23.79
EPS (TTM)6.69
Earnings DateJan 25, 2022
Forward Dividend & Yield4.24 (2.65%)
Ex-Dividend DateNov 22, 2021
1y Target Est187.76
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
-4% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for JNJ

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Johnson & Johnson
    Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total sales are generated in the United States.
    Fair Value
    Economic Moat
    8 days agoMorningstar
View more